Latest News & Updates
Breaking News
25 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Lupin Gains FDA Establishment Inspection Report for Ankleshwar Facility Following Pre-Approval Inspection Closure
Lupin's Ankleshwar site receives FDA EIR after a product-specific pre-approval inspection in March 2026, clearing a key compliance checkpoint.
Pharma Now Editorial Team
Sanofi Gains FDA Priority Review for Venglustat in Gaucher Disease Type 3
FDA grants Priority Review to Sanofi's venglustat NDA for Gaucher disease type 3, with a PDUFA date of 25 November 2026.
Pharma Now Editorial Team
Novo Nordisk Presents Late-Stage Pipeline and Semaglutide Expansion Data at ADA 2026
Novo Nordisk's ADA 2026 data across semaglutide and GLP-1 pipeline programs signals near-term API and CDMO demand shifts.
Pharma Now Editorial Team
Asahi Kasei Licenses DAR-Control ADC Platform to Advance Single- and Dual-Payload Conjugate Manufacturing
Asahi Kasei licenses a DAR-control ADC platform enabling precise payload attachment in single- and dual-payload conjugates, with direct implications for process validation and CMC filings.
Pharma Now Editorial Team
